Category: Infectious Diseases

Infectious Diseases

FDA Grants EUA for Multiplex PCR Assay for Viral Skin Lesions

The assay from Seegene USA simultaneously detects and differentiates herpes simplex virus, varicella-zoster virus, and monkeypox virus.

Infectious Diseases

Study Shows Molecular Test Improves Treatment Accuracy for Vaginal Infections

A randomized trial found Cepheid’s Xpert Xpress MVP test improved appropriate treatment rates for vaginitis within 24 hours compared to standard diagnostic methods.

Infectious Diseases

Andes Virus Shifts Hantavirus Conversation for US Labs

Emerging Andes virus cases—capable of person-to-person transmission—are prompting US clinical labs to reassess hantavirus protocols and consider travel and epidemiologic exposures beyond rodent contact.

Emerging & Zoonotic Diseases

Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases

A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.

Flu & Respiratory Infections

CE Mark Granted for Rapid Bacterial vs Viral Infection Test

The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.

Gastrointestinal Infections

FDA Clears Cepheid’s Multiplex GI Pathogen Panel

The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.

Sexually Transmitted Diseases

Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer

Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.